Terug
46
62
Dagbereik
€ 350,76
€ 358,00
52-Weeksbereik
€ 261,43
€ 391,29
Volume
1.831.434
50D / 200D Gem.
€ 359,42
/
€ 316,58
Vorige Slotkoers
€ 348,43
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 24,7 | 0,3 |
| P/B | 22,0 | 3,0 |
| ROE % | 106,1 | 3,7 |
| Net Margin % | 21,0 | 3,8 |
| Rev Growth 5Y % | 9,1 | 10,0 |
| D/E | 6,3 | 0,2 |
Koersdoel Analisten
Hold
€ 347,73
-1.8%
Low: € 185,00
High: € 432,00
Forward K/W
15,80
Forward WPA
€ 22,41
WPA Groei (sch.)
+0,0%
Omzet Sch.
37,84B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 27,53
€ 26,56 – € 29,06
|
42,75B | 4 |
| FY2029 |
€ 25,48
€ 24,59 – € 26,90
|
41,40B | 4 |
| FY2028 |
€ 24,22
€ 18,95 – € 32,36
|
39,77B | 10 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-03 | € 4,73 | € 5,29 | +11,8% |
| 2025-11-04 | € 5,02 | € 5,64 | +12,4% |
| 2025-08-05 | € 5,28 | € 6,02 | +14,0% |
| 2025-05-01 | € 4,27 | € 4,90 | +14,8% |
| 2025-02-04 | € 5,04 | € 5,31 | +5,4% |
| 2024-10-30 | € 5,11 | € 5,58 | +9,2% |
| 2024-08-06 | € 4,98 | € 4,97 | -0,2% |
| 2024-05-02 | € 3,88 | € 3,96 | +2,1% |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 |
Santos Esteban
EVP, Operations
|
other | 5.621 | € 366,21 | € 2.058.466,41 |
| Mar 16, 2026 |
Gordon Murdo
EVP, Global Commercial Ops
|
other | 6.691 | € 366,21 | € 2.450.311,11 |
| Mar 16, 2026 |
Graham Jonathan P
EVP & Gen. Counsel & Sec.
|
other | 5.353 | € 366,21 | € 1.960.322,13 |
| Mar 16, 2026 |
Miller Derek
SVP, Human Resources
|
other | 1.616 | € 366,21 | € 591.795,36 |
| Mar 3, 2026 |
REESE DAVID M
EVP & Chief Technology Officer
|
grant | 12.063 | — | — |
| Mar 3, 2026 |
Grygiel Nancy A.
SVP & CCO
|
grant | 2.010 | — | — |
| Mar 3, 2026 |
Miller Derek
SVP, Human Resources
|
grant | 3.484 | — | — |
| Mar 3, 2026 |
Khosla Rachna
SVP, Business Development
|
grant | 1.876 | — | — |
| Feb 19, 2026 |
Busch Matthew C.
VP, Finance & CAO
|
sell | 1.000 | € 375,79 | € 375.790,00 |
| Nov 12, 2025 |
Khosla Rachna
SVP, Business Development
|
sell | 890 | € 336,24 | € 299.255,56 |
| Aug 8, 2025 |
HOLLEY CHARLES M
Director
|
grant | 147 | — | — |
| Aug 8, 2025 |
ISHRAK OMAR
Director
|
grant | 121 | — | — |
| May 23, 2025 |
Jacks Tyler
Director
|
grant | 809 | — | — |
| May 23, 2025 |
ECKERT ROBERT
Director
|
grant | 809 | — | — |
| May 23, 2025 |
Garland Greg C.
Director
|
grant | 809 | — | — |
| May 23, 2025 |
Austin Wanda M
Director
|
grant | 809 | — | — |
| May 6, 2025 |
ISHRAK OMAR
Director
|
grant | 129 | — | — |
| May 6, 2025 |
Busch Matthew C.
VP, Finance & CAO
|
grant | 4.139 | — | — |
| May 2, 2025 |
Bradway Robert A
Chairman, CEO and President
|
other | 4.833 | € 283,78 | € 1.371.508,74 |
| May 2, 2025 |
Griffith Peter H.
EVP & CFO
|
other | 1.367 | € 283,78 | € 387.927,26 |
Dividend History
7 yr streakYield
0,03%
Payout Ratio
0,66%
Growth (3Y)
7,05%
Growth (5Y)
8,27%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 15, 2026 | Jun 05, 2026 | € 2,52 | 2,77% |
| Feb 13, 2026 | Mar 06, 2026 | € 2,52 | 2,62% |
| Nov 21, 2025 | Dec 12, 2025 | € 2,38 | 2,82% |
| Aug 22, 2025 | Sep 12, 2025 | € 2,38 | 3,20% |
| May 16, 2025 | Jun 06, 2025 | € 2,38 | 3,40% |
| Feb 14, 2025 | Mar 07, 2025 | € 2,38 | 3,14% |
| Nov 18, 2024 | Dec 09, 2024 | € 2,25 | 3,23% |
| Aug 16, 2024 | Sep 06, 2024 | € 2,25 | 2,76% |
| May 16, 2024 | Jun 07, 2024 | € 2,25 | 2,78% |
| Feb 15, 2024 | Mar 07, 2024 | € 2,25 | 2,99% |
| Nov 16, 2023 | Dec 08, 2023 | € 2,13 | 3,17% |
| Aug 17, 2023 | Sep 08, 2023 | € 2,13 | 3,16% |
| May 17, 2023 | Jun 08, 2023 | € 2,13 | 3,62% |
| Feb 14, 2023 | Mar 08, 2023 | € 2,13 | 3,30% |
| Nov 16, 2022 | Dec 08, 2022 | € 1,94 | 2,73% |
| Aug 17, 2022 | Sep 08, 2022 | € 1,94 | 3,02% |
| May 16, 2022 | Jun 08, 2022 | € 1,94 | 3,03% |
| Feb 14, 2022 | Mar 08, 2022 | € 1,94 | 3,22% |
| Nov 15, 2021 | Dec 08, 2021 | € 1,76 | 3,39% |
| Aug 16, 2021 | Sep 08, 2021 | € 1,76 | 2,98% |
Belangrijkste Punten
Revenue grew 9,05% annually over 5 years — modest growth
Earnings grew 88,53% over the past year
ROE of 106,10% indicates high profitability
Net margin of 20,99% shows strong profitability
Debt/Equity of 6,31 — high leverage
Generating 8,10B in free cash flow
Groei
Revenue Growth (5Y)
9,05%
Revenue (1Y)9,92%
Earnings (1Y)88,53%
FCF Growth (3Y)4,91%
Kwaliteit
Return on Equity
106,10%
ROIC12,66%
Net Margin20,99%
Op. Margin29,06%
Veiligheid
Debt / Equity
6,31
Current Ratio1,14
Interest Coverage3,88
Waardering
P/E Ratio
24,74
Forward P/E15,80
P/B Ratio22,04
EV/EBITDA22,13
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,92% | Revenue Growth (3Y) | 14,16% |
| Earnings Growth (1Y) | 88,53% | Earnings Growth (3Y) | 7,14% |
| Revenue Growth (5Y) | 9,05% | Earnings Growth (5Y) | 6,95% |
| Profitability | |||
| Revenue (TTM) | 36,74B | Net Income (TTM) | 7,71B |
| ROE | 106,10% | ROA | 8,51% |
| Gross Margin | 70,80% | Operating Margin | 29,06% |
| Net Margin | 20,99% | Free Cash Flow (TTM) | 8,10B |
| ROIC | 12,66% | FCF Growth (3Y) | 4,91% |
| Safety | |||
| Debt / Equity | 6,31 | Current Ratio | 1,14 |
| Interest Coverage | 3,88 | ||
| Dividends | |||
| Dividend Yield | 0,03% | Payout Ratio | 0,66% |
| Dividend Growth (3Y) | 7,05% | Dividend Growth (5Y) | 8,27% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 24,74 | Forward P/E | 15,80 |
| P/B Ratio | 22,04 | P/S Ratio | 5,19 |
| PEG Ratio | 0,26 | Forward PEG | N/A |
| EV/EBITDA | 22,13 | Fwd EV/EBITDA | 13,86 |
| Forward P/S | 5,04 | Fwd Earnings Yield | 6,33% |
| FCF Yield | 4,25% | ||
| Market Cap | 190,79B | Enterprise Value | 236,27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 36,74B | 33,42B | 28,19B | 26,32B | 25,98B |
| Net Income | 7,71B | 4,09B | 6,72B | 6,55B | 5,89B |
| EPS (Diluted) | 14,23 | 7,56 | 12,49 | 12,11 | 10,28 |
| Gross Profit | 26,01B | 20,57B | 19,78B | 19,92B | 19,53B |
| Operating Income | 10,68B | 7,26B | 7,90B | 9,57B | 7,64B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90,59B | 91,84B | 97,15B | 65,12B | 61,17B |
| Total Liabilities | 81,93B | 85,96B | 90,92B | 61,46B | 54,47B |
| Shareholders' Equity | 8,66B | 5,88B | 6,23B | 3,66B | 6,70B |
| Total Debt | 54,60B | 60,10B | 64,61B | 38,95B | 33,31B |
| Cash & Equivalents | 9,13B | 11,97B | 10,94B | 7,63B | 7,99B |
| Current Assets | 29,06B | 29,03B | 30,33B | 22,19B | 19,39B |
| Current Liabilities | 25,49B | 23,10B | 18,39B | 15,69B | 12,18B |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#83 of 218
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#89 of 332
Recente Activiteit
Ingestapt
Capital Light Compounder
Mar 24, 2026
Ingestapt
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026